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Abstract
Background:  Recent studies revealed a predictive value of lymphatic vessel invasion (L1) for the nodal
metastasizing and poor prognosis in malignant tumors at different sites. The monoclonal antibody D2-40
(podoplanin) stains specifically endothelial cells of lymphatic vessels and improves the search for L1. However, the
importance of this immunohistochemical staining was not investigated in squamous cell carcinomas (SCC) of
larynx and hypopharynx.
Aim: This study was performed to compare the diagnostic potential of convential and immunohistochemical
determination of L1 in SCC of larynx and hypopharynx with special respect to the predictive value for nodal
metastasizing and prognosis.
Methods: 119 SCCs of the larynx (n = 70) respectively hypopharynx (n = 49) were investigated. The lymphatic
vessel invasion was assessed by conventional method (HE stain) and immunohistochemical staining with an
antibody against D2-40 (DAKO, Germany). Immunohistochemistry was performed in accordance with
manufacturer's protocol. L1 was searched microscopically in a standardized magnification (×200) in serial sections
of tumor samples (1 section per cm tumor diameter).
Results:  The immunohistochemical investigation did not show significant advantages for the prediction of
regional nodal metastases. Despite a low sensitivity (< 50%) in both methods, the specifity can reach 80%. The
negative predictive value in both methods seems acceptable (up to 80%), whereas the positive predictive value is
not higher than 64%. Cases with L1 detected either conventionally or immunohistochemically did not show a
significant shorter survival than cases with L0. However, a non-significant shorter survival was found. Only in SCC
of hypopharynx, a combination of both methods revealed patients with a significant worse prognosis.
Conclusion: The status of lymphatic vessel invasion should be documented in standardized tumor reports. A
benefit of an additional immunohistochemical investigation was not found, for the daily routine HE-stain seems
sufficient.
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Background
Squamous cell carcinomas (SCC) are the most common
malignant tumors of the larynx and hypopharynx. The
tumor morphology does not differ at both sites, but a dif-
ferent behavior in nodal metastasizing is well known.
Whereas glottic laryngeal SCC metastasize late and in a
lower number, SCC of hypopharynx may develope metas-
tases early in the course of disease. Own investigations
revealed metastases in up to 41% of a series of glottic SCC
and up to 92% of carcinomas of hypopharynx (tumor
stages > pT1) [1]. Apart from statistical considerations,
tumors at both sites can either metastasize in a early stage
or be free of metastases even in advanced stages.
The extent of surgery regarding the neck dissection (ND)
depends on the clinical stage of nodal involvement. A
problem are occult nodal metastases or micrometastases.
Up to 30% of cN0 cases show metastases in histological
investigations [2].
A better prediction of metastatic potential could influence
therapeutical approaches – in cases with low risk extended
surgery with (complete) neck dissection could be avoided
and replaced e.g. by local clinical controls [3].
Some efforts have been undertaken for finding predictive
parameters, up to now without substantive success [1]. In
particular parameters obtainable in the routine histomor-
phological investigation seem attractive. One point of
interest is the importance of lymphatic vessel invasion (L1
according with the TNM classification of UICC). From a
mechanistical point of view, it could be an important con-
dition for development of nodal metastases. A higher
degree of lymphangiogenesis and lymphatic vessel den-
sity is associated with increasing frequency of nodal
metastases [4-7]. But the lymphatic vessel density is diffi-
cult to graduate in the daily work, whereas the assessment
of lymphatic vessel invasion is more easy. However, most
of recently published studies have not found a significant
correlation of conventional determination of L1 in HE-
stain (hematoxylin-eosin) with nodal metastasizing. Cur-
rently, for some malignant tumors (e.g. breast carcinoma,
carcinoma of uterine cervix, or esophageal carcinoma) a
significant relation between L1 and N+ was reported using
immunohistochemical methods for the assessment of L1
[8-10].
The monoclonal antibody D2-40 (podoplanin) recog-
nizes a fixation-resistant O-linked sialoglycoprotein
epitope on lymphatic endothelium. Endothelial cells of
blood vessels remain negative in this staining [11,12]. To
our knowlegde, no study is published, which investigated
the value of an additional immunohistochemical analysis
looking for lymphatic vessel invasion in SCC of the larynx
or hypopharynx.
Therefore, we performed this study to evaluate the diag-
nostic value of immunohistochemistry in the assessment
of lymphatic vessel invasion in SCC of larynx and
hypopharynx with special respect to predict the risk of
nodal metastases and individual prognosis.
Materials and methods
119 cases (between 1996 up to 2002, follow up at least 5
years) with 70 SCC of glottic larynx and 49 SCC of
hypopharynx were determined. Complete clinical data of
all patients were available. Table 1 shows the distribution
of cases and main clinical characteristics, Figure 1 indi-
cates the distribution of cases in several tumor stages
accordingly to TNM classification for malignant tumors of
UICC. All patients included in this study were treated by
complete laryngectomy with ND, with exception of laryn-
geal pT1 tumors, in which metastasizing was excluded by
clinical investigations (e.g. ultrasound). The latter were
treated by local tumor excision (hemilaryngectomy).
Apart from these cases, all others received a postoperative
radiotherapy.
Only cases with well preserved tumor specimen (no autol-
ysis, well formalin-fixed, no mechanical or thermical
alterations) were included. One tumor sample per cm
tumor diameter was investigated.
For standard staining and immunohistochemistry serially
prepared sections were examined. In large tumors, espe-
cially areas of the lateral and deep tumor borders (front of
invasion) were investigated.
The histomorphological diagnoses of SCC and its grading
was reevaluated by an experienced pathologist. The
resected lymph nodes were also reevaluated.
Immunohistochemistry was performed in a standard pro-
cedure of daily routine. Briefly, sections (2–5 μm) for
immunohistochemistry were air-dried overnight (at least
12 hours), dewaxed, rehydrated in descending concentra-
tions of ethanol before being heated for antigen unmask-
ing in 10 mM citric acid (pH 5.5) for five minutes. After
rinsing with distilled water, slides were washed in phos-
phate buffered saline (PBS). For staining, the ADVANCE
kit (DAKO, Germany) was used in accordance to the man-
ufacturer's protocol. The antibody for D2-40 (clone D2-
40, DAKO, Germany) was used in a dilution of 1:800.
All slides were determined microscopically with standard-
ized magnification (×200). Only undoubted lymphatic
vessel invasion was assessed positive (L1) in conventional
(HE) stain. This means, L1 was diagnosed in cases with
tumor embolism in morphologically clear lymphatic ves-
sels with identifiable endothels and thin vessel wall, an
example is given in Figure 2a. For immunohistochemicalWorld Journal of Surgical Oncology 2009, 7:25 http://www.wjso.com/content/7/1/25
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analysis of L1, all samples contained an internal positive
control of staining in tumor-free lymphatic vessels (Figure
2b). Tumor thrombembolism in vessels with stained
endothelium in immunoperoxidase was the criterion for
L1 in immunohistochemical analysis (Figure 2c, d). The
number or location of invaded vessels was not respected,
because the biological value of differences between one or
more invaded vessels remains unclear and a cut-off is not
definable. The different density of lymphatic vessels in lar-
ynx and hypopharynx was not considered, but cases with-
out peritumorous lymphatic vessels were excluded before
starting the study. Definite invading of non-lymphatic
vessels (tumorembolism with fibrinous reaction, broad
muscular wall of the vessel, or negativity in immunoper-
oxidase (Figure 2d, e)) were excluded.
For survival analysis, the overall survival was considered.
The disease-free survival was not respected. Only synchro-
nous nodal metastases at time of primary diagnosis were
included as N+. Distant metastases (e.g. lung, liver) out of
regional lymph nodes were not considered, because their
Distribution of cases in different tumor stages Figure 1
Distribution of cases in different tumor stages.
Table 1: Main characteristics of cases included in the study.
Larynx n = 70 Hypopharynx n = 49
Median Age [Years] 62.2 (45–85) 57.2 (38–75)*
Male:Female 66:4 43:6
Median tumor size [cm] 2.5 (0.6–5.2) 3.4 (1.0–6.5)*
Grading (G1/G2/G3) 5/43/22 1/25/23
Median number of investigated lymph nodes 30.4 (4–76) 31.5 (5–82)
N0/N+ 30/40 (43% N+) 35/14 (71% N+)*
Median number of nodal metastases in N+ 2 (1–25) 3 (1–17)
* P < 0.05World Journal of Surgical Oncology 2009, 7:25 http://www.wjso.com/content/7/1/25
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appearance is rather a result of invasion of blood vessels
than lymphatic vessels.
L-status L0/L1 (with both methods) was correlated with
nodal involvement, stage and size of the tumor, and sur-
vival. Sensitivity and specificity were calculated. Data were
processed by Microsoft Excel and SPSS for descriptive sta-
tistic values, Student's t-test, Chi-square test, U-test by
Mann-Whitney, or log rank test. Data were analyzed for
both separated groups (larynx, hypopharynx) and overall.
Results
Tumor size (P < 0.001), tumor stage T (larynx P < 0.001;
hypopharynx P < 0.05), and grading G (larynx P < 0.001;
hypopharynx P < 0.05) were significant higher in metasta-
sized SCC at both anatomic sites.
Overall (n = 119), 37.8% of tumors showed L1 within the
conventional assessment, and 35.3% using the immuno-
histochemical method. 50.4% showed L1 either conven-
tionally or immunohistochemically. In 32.7% a
discrepancy regarding L1 status was found between both
methods, 26.3% of L1 cases in immunohistochemistry
were conventionally negative (L0). The reliablity for non-
conformance was kappa = 0.27.
The results in the different groups are indicated in table 2.
The sensitivity and specificity of L1 regarding the predic-
tive value of nodal metastasizing was low (Figure 3).
The correlation of L1 and nodal involvement revealed a
significant better correlation between L1 (conventionally
or immunohistochemically) with N+ in cases with more
than one nodal metastasis (P < 0.05). The other results are
given in table 3.
In survival analysis, parameters apart from L-status
showed a significant shorter survival with increasing
tumor stage T (P = 0.038) and N+ (P = 0.0048, also signif-
icant in multivariate analysis). The L-status (L0/L1) did
not influence the survival significantly, even though a
lymphatic vessel invasion was accompanied by a shorter
survival (figure 4). However, the results were better for
hypopharyngeal SCC, the combination of both methods
showed significant differences between L0 and L1 (P =
0.049, log rank test), independent of nodal status.
Discussion
This study was performed to assess the predictive value for
nodal metastasizing of lymphatic vessel invasion (L1)
using the conventional and immunohistochemical
method in squamous cell carcinomas (SCC) of larynx and
hypopharynx. The used antibody D2-40 (podoplanin)
recognizes specifically endothelium of lymphatic vessels,
whereas blood vessels remain negative [12,13].
a) Lymphangiosis carcinomatosa in conventional staining (HE  ×400); b) Specific reaction in lymphatic vessel endothelium  (right) and no reaction in a blood capillary (left) (D2-40  ×400); c) and d) Different types of lymphatic vessel invasion:  in c) single larger vessel, in d) some small vessels surrounded  by inflammatory response (D2-40 ×400); e) tumor thromem- bolism in a blood vessel (note: erythrocytes) (HE ×400) – f)  negative for D2-40 (D2-40 ×400) Figure 2
a) Lymphangiosis carcinomatosa in conventional 
staining (HE ×400); b) Specific reaction in lymphatic 
vessel endothelium (right) and no reaction in a blood 
capillary (left) (D2-40 ×400); c) and d) Different types 
of lymphatic vessel invasion: in c) single larger vessel, 
in d) some small vessels surrounded by inflammatory 
response (D2-40 ×400); e) tumor thromembolism in 
a blood vessel (note: erythrocytes) (HE ×400) – f) 
negative for D2-40 (D2-40 ×400).World Journal of Surgical Oncology 2009, 7:25 http://www.wjso.com/content/7/1/25
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With the background of unknown individual potential for
metastasising, this study confirmed data of conventional
assessment of L1, which argues against a significant pre-
dictive value of this investigation [1]. However, apart from
metastases greater than 2 mm, micrometastases are possi-
ble. Different authors have described a prognostic impact
of detecting micrometastases [14]. We did not search for
micrometastasis < 1 mm with immunohistochemical
methods (e.g. Pan-Keratin AE1/3) in this study, but small
metastases with 1–2 mm were found in single cases and
staged as N+. Nevertheless, the importance of L1 for the
development of micrometastasis < 1 mm should be eval-
uated in further studies.
The negative predictive value reached up to 80%, whereas
a positive prediction is not possible. The reason is the dis-
crepance between the development of lymphatic vessel
invasion in nodal negative cases, which may develope the
metastases later in the course of disease.
The decision between lymphatic and blood vessel inva-
sion shows a high interobserver variability, because the
morphological discrimination between small lymphatic
and blood vessels is difficult. The question was, whether
the immunohistochemical detection of lymphatic vessles
can improve the predictive value of this investigation.
However, the specifity and sensitivity was not better with
support of immunohistochemical staining. This results
did not confirm the reported advantages of D2-40 stain-
ing in other tumors [8,15,16]. Another item is the impor-
tance of lymphatic vessel density [4,5,7,17], whose
investigation was not the aim of this study. Some authors
found a higher potential for metastasizing in tumors with
increased density of lymphatic vessels, however, the meas-
urement of vessel density does not seem practicable in the
daily routine.
The immunohistochemical investigation seems at first
appearance a convenient and reliable method. Some cases
negative in conventional investigation showed L1 in
immunohistochemistry. However, several cases positive
Sensitivity and specifity of the different methods for evaluation of lymphatic vessel invasion concerning the status of nodal  metastasizing Figure 3
Sensitivity and specifity of the different methods for evaluation of lymphatic vessel invasion concerning the sta-
tus of nodal metastasizing.World Journal of Surgical Oncology 2009, 7:25 http://www.wjso.com/content/7/1/25
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for L1 conventionally became negative in immunohisto-
chemistry. One reason could be the fragile endothelial
layer in lymphatic vessels, which can be destroyed by
thrombembolism of tumor cells. The presence of the
endothelium is needed for the success of this analysis.
Another reason is, that the conventional assessment can-
not distinguish between lymphatic and blood vessels
(apart from cases with typical pictures of blood vessel
invasion, e.g. embolism with degenerated erythrocytes
and fibrin precipitation). In these cases, a positive result of
L1 could be false positive and the correct classification
would be V1 (venous invasion). With regard of this point,
the immunohistochemical assesment has some advan-
tages, however, they are not important for the predictive
potential of this investigation.
Our investigations were not suitable to explain, why
laryngeal carcinomas show a lower potential for nodal
metastasizing (including advanced tumor stages) than
hypopharyngeal SCC.
Conclusion – clinical applicability
It seems not possible to predict the nodal metastasizing of
laryngeal or hypopharyngeal SCCs with the status of lym-
phatic vessel invasion. The immunohistochemical detec-
tion is not helpful in the daily routine. Nodal
metastasizing was not found in 33% of tumors showing
L1 defined from the results of either methods. The value is
higher than that from the results of only one examination,
standard or immunohistochemical staining. From these
results, both methods together have little value for the
prediction of N+. However, the negative predictive value
is acceptable.
Recommendations regarding the necessity of neck dissec-
tion (ND) in cN0 cases are difficult, however, in border-
line cases the (modified) ND should be performed in
tumors with L1. In L0 cases with no other clinical argu-
ments for ND, the renouncement of ND flanked by regu-
lar clinical controls seems acceptable.
Despite the not-significant shorter survival of patients
with L1 in comparison with patients with L0, the status of
lymphatic vessel invasion (L0/L1) should mandatory be
Table 2: Results of assessment of L-status conventionally and immunohistochemically in both groups.
Larynx (n = 70) Hypopharynx (n = 49)
n % n % P (Chi-square)
conventional negative 51 72.86% 29 59.18% 0.12
positive 19 27.14% 20 40.82%
D2-40 negative 45 64.29% 32 65.31% 0.91
positive 25 35.71% 17 34.69%
either or negative 36 51.43% 23 46.94% 0.63
positive 34 48.57% 26 53.06%
discrepancy no 46 65.71% 34 69.39% 0.67
yes 24 34.29% 15 30.61%
D2-40 positive in conventionally L0 15 21.43% 6 12.24% 0.19
Table 3: L-status and nodal involvement. Positive and negative 
predictive values.
N0 N+
n % n % P (Chi-square
conventional L0 43 79.63% 37 56.92% 0.0077
L1 11 20.37% 28 43.08%
D2-40 L0 42 77.78% 35 53.85% 0.0059
L1 12 22.22% 30 46.15%
either or L0 36 66.67% 23 35.38% 0.00061
L1 18 33.33% 42 64.62%World Journal of Surgical Oncology 2009, 7:25 http://www.wjso.com/content/7/1/25
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Survival (Kaplan-Meier) for SCC with L0 (blue) and L1 (green) for the different methods of investigation: a) + b) conventional;  P = 0.4 resp. P = 0.01. c) + d) D2-40 immunohistochemistry; P = 0.3 resp. P = 0.17 e) + f) both methods together; P = 0.2 resp.  P = 0.049 (log rank) Figure 4
Survival (Kaplan-Meier) for SCC with L0 (blue) and L1 (green) for the different methods of investigation: a) + 
b) conventional; P = 0.4 resp. P = 0.01. c) + d) D2-40 immunohistochemistry; P = 0.3 resp. P = 0.17 e) + f) both 
methods together; P = 0.2 resp. P = 0.049 (log rank).Publish with BioMed Central    and   every 
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reported in histopathological diagnoses for a standard-
ized tumor documentation.
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